Everyone in your Telegram group is arguing whether to apply for this month’s SSB or wait for next month’s slightly higher rate. I explain why that debate optimises inside a range that was never going to fund your retirement, and what number should decide whether this cash belongs in a liquidity bucket at all. If you’ve ever wondered whether your SSB should even exist when your CPF SA is doing better, this episode is for you.

Key takeaways:

• Current SSB ten-year average is 2.25%, next month projected at 2.33%, both below the 3.2% forensic floor

• CPF Special Account yields 4% guaranteed, already beating every SSB rate on the table

• SSBs earn their keep for liquidity, not retirement income, know which job your cash is doing

• The real decision is upstream, whether this money belongs in a safety bucket or should be working harder

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

MAS just rolled out tax breaks to stop fund managers from walking to Hong Kong. That policy fight doesn’t stay in the headlines, it lands in your bank’s non-interest income, and eventually your dividend. I walk through why fee income growth matters for DBS, UOB, OCBC, and why it doesn’t fix today’s yield gap problem.

Key takeaways:

• MAS announced three measures on Wednesday, tax exemption from YA 2027, new hedge fund programme, and a work pass track for senior investment professionals

• OCBC’s non-interest income hit 43.9% of total, up 8.2 percentage points this half

• Fee income growth is good for business, but doesn’t move DBS, UOB, OCBC off the 4.7% yield hurdle today

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

I walk through Koh Brothers Eco Engineering’s S$57.6 million legal dispute disclosure landing hours before a shareholder vote on its mainboard transfer, and why the sequencing matters more than the headline number. Then I flag how SIA’s July traffic beat and lower share price actually narrow a yield gap in my framework, without flipping the verdict. This is governance pattern tracking and yield mechanics, not a buy or sell call.

Key takeaways:

• Koh Brothers disclosed three legal disputes totalling up to S$57.6m in potential liabilities on the same day as its mainboard vote

• The stock fell 2.6% to 11.4 cents on Monday, before the disclosure, so price moved first, filing came after

• SIA’s July passenger traffic rose 2.6%, load factor at 86%, but the share price drop from 7.77 to 7.10 narrows the yield gap

• Zone verdicts are timing signals, not permanent rejections, hold makes sense with long runway or surplus capital

• CTA: Full forensic breakdown on Substack. Early alerts on Telegram.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

AEM just forced me to change a forensic call I had kept in the red zone. First half 2026 revenue rose almost 30% to S$247 million, while net profit surged 876% to S$30.8 million, and a restored dividend pushed the provisional yield above my 3.2% floor. I explain what changed, why the 4.7% hurdle still matters, and why the answer looks very different for an existing shareholder than someone entering at Thursday’s S$11 price. Iggy’s Forensic Zone: Zone 4, Caution.

Key takeaways:

• Revenue rose almost 30% to S$247 million.

• Net profit jumped 876% to S$30.8 million.

• AEM declared a 2.4 cent interim dividend.

• The combined 3.7 cent payout implies roughly a 3.3% yield.

• The 4.7% hurdle still sits above AEM’s current yield.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

I look past ST Engineering’s S$2.9 billion contract headline to ask a more uncomfortable question for Singapore income investors: does a healthy business automatically make a useful dividend stock? The balance sheet passes comfortably, but the ordinary dividend at around S$10.08 delivers only about 1.6 percent, leaving a significant gap for CPF and SRS income planning. Thursday’s first half 2026 results could be the moment this call gets properly tested.

Key takeaways:

• S$2.9 billion in contracts spans aerospace, defence, public security, urban solutions, and satcom.

• Net debt sits at 2.77 times earnings, below Iggy’s caution threshold.

• Interest coverage is 5.77 times, showing comfortable debt-servicing capacity.

• The ordinary dividend yields about 1.6 percent, below the 3.2 percent Forensic Floor.

• First half 2026 results arrive before the market opens on Thursday.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

DBS Research has built a credible case for seven Singapore-listed deep-value stocks, including Keppel and SingTel. I take that framework seriously, then test two names through a different lens, can their recurring distributions actually support a retirement portfolio today? This is the gap between an asset-unlocking story and the cashflow reality showing up in your CPF or SRS plan.

Key takeaways:

• DBS divides the value-unlocking journey into expectations, delivery, and reward.

• Keppel has monetised S$14.9 billion in non-core assets since October 2020.

• Keppel’s 2.96% ordinary yield misses my 4.7% income hurdle.

• Even generous Keppel distributions reach only about 4.09%.

• SingTel’s 3.03% core yield excludes its asset-funded value-realisation dividend.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

OCBC and UOB both beat second-quarter expectations, but the headline hides a crucial difference. I explain why OCBC’s S$2.22 billion result looks broad-based, while UOB’s S$1.48 billion profit included a non-recurring gain and came with lower fee-growth guidance. For anyone relying on bank dividends for CPF, SRS, or household income, the forward message matters more than yesterday’s profit number.

Key takeaways:

• OCBC net profit rose 22% to S$2.22 billion.

• OCBC’s interim dividend increased to S$0.47 from S$0.41.

• UOB’s other non-interest income jumped 28%, partly from asset divestments.

• UOB reduced 2026 fee-growth guidance from high single-digit to low single-digit.

• UOB’s S$0.88 dividend was up from S$0.85 ordinary payment.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

A 14.6% jump in half-year DPU to 8.77 cents sounds like a win for your CPF or SRS income. But the release says almost nothing about gearing, which was already creeping toward my 35% ceiling. Listen in as Angela and I walk through what’s confirmed, what’s still open, and why I’m not declaring victory yet.

Key takeaways:

• Half-year DPU rose 14.6% to 8.77 cents, but this is not a trailing twelve-month yield.

• The release is silent on gearing, so we cannot confirm if it has crossed 35%.

• Revenue actually slipped 1.6%, making the DPU growth even more interesting to unpack.

• I’m waiting on full financials and the second half DPU before moving the zone call.

• CTA: Full forensic breakdown on Substack. Early alerts on Telegram.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Seatrium’s half-year profit just jumped 158% to S$373 million, but once you strip out one-off divestment gains, the core profit story is closer to 54% growth and a complete absence of interim dividends for your CPF and SRS income. In this episode, I walk through why the name stays in Iggy’s Forensic Zone: Zone 5, Structural Risk, and why missing interest coverage and cash flow numbers matter more than any percentage in the headline. We also unpack Jardine C&C’s unusual Toyota share payout structure, Frasers L&C’s strong rental reversions, MPACT’s softer DPU, and Great Eastern’s profit surge, so you can see which jumps are real operating strength and which are just asset reshuffles. It is the kind of kopi-chat breakdown that keeps your Bedok retirement plan honest, before you let a single results-day headline sway your REIT or dividend choices.

Key takeaways:

• Seatrium’s reported net profit is up 158% to S$373 million, but core profit grows 54% once divestment gains are removed.

• No interim dividend from Seatrium despite stronger profits, a clear warning for CPF and SRS income planning.

• Jardine C&C’s US$0.73 special dividend splits into cash and Toyota shares, returning real value in a less familiar form.

• Frasers L&C posts rental reversions of 8.2% incoming versus outgoing and 17.9% average to average, signalling genuine pricing power in its leases.

• MPACT’s DPU drifts lower while Great Eastern’s profit doubles with a 35 cent dividend, showing how similar percentage jumps can mean very different things for your portfolio income.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

In this Daily Pulse, I walk through why Seatrium’s “material improvement” in H1 net profit is driven mainly by divestment gains and margin tweaks, not yet by proven recurring cashflow. We also cover MAS’ surprise second tightening of monetary policy, plus fresh numbers from iFast and Raffles Medical, to show how a red STI day can still hide quietly positive stories for a Bedok HDB portfolio. The real tension tonight is simple, your CPF and SRS income depends on interest coverage and cash conversion, not on one half-year profit headline. Iggy’s Forensic Zone: Zone 5, Red.

Key takeaways:

• Seatrium’s H1 profit uplift is mainly from one-off divestment gains, not recurring cash.

• MAS tightened policy again, allowing a stronger Singdollar to contain imported inflation pressure.

• iFast’s Q2 net profit rose 35 per cent to around S$29.8 million, with revenue up nearly 38 per cent.

• Raffles Medical’s first half net profit slipped 9.6 per cent to S$29 million, with revenue down 6.7 per cent.

• A single STI down day masked individual winners and losers, so stock-level news mattered more than the index headline.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Today I walk Angela through a rare good news day, three SGX REITS all posting real double digit DPU growth and a new 20 year Singapore green bond setting the backdrop for your retirement income. We unpack what is really driving Keppel DC, OUE REIT and Alpha Integrated, and why the same DPU headline can hide very different engines under the hood. We then connect that to Singapore’s first 20 year sovereign green bond at 2.4 percent, and what that yield says about long term CPF, SRS and REIT income for a Bedok household investor. If you listen on the MRT, you should step off knowing exactly which numbers to check before you celebrate any “DPU up” headline.

Key takeaways:

• OUE REIT’s H1 DPU jumps 28.6 percent to 1.26 cents, driven by hospitality and Salesforce Tower income.

• Keppel DC REIT’s DPU rises 11.3 percent to 5.714 cents, powered by rent escalations and data centre acquisitions.

• Alpha Integrated REIT delivers 19.4 percent DPU growth to 2.03 cents, mainly from cost savings and stronger leasing.

• MLT recycles its portfolio by divesting China and Changi assets, tightening focus on core properties.

• Singapore’s first 20 year green bond prices S$2.6 billion at 2.4 percent, giving a new reference point for long term income.

CTA: Full forensic breakdown on Substack. Early alerts on Telegram.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

The market looked sleepy today, but under the surface names like CSE Global, YZJ, UMS and IX Biopharma were moving a lot harder than the STI, while tiny counters like HS Optimus and Prospera Global printed eye-catching double digit percentage swings at fractions of a cent. In this Daily Pulse, I walk Angela through what actually matters for a CPF or SRS portfolio on days like this, how to separate real signals from statistical noise, and why a single trade at S$0.01 can make the gainers list look exciting without changing anyone’s retirement. We also touch on Yeo Hiap Seng’s CEO transition to Adrian Ho from Nestle, Foundation Healthcare’s post IPO stabilising trades, and CICT’s Paragon reconfiguration, all pieces that tug on future REIT and dividend income in small but real ways.

Key takeaways:

• Why a 6% move in CSE can matter more than a 17% jump at S$0.004.

• How penny stock swings at one cent warp your sense of risk and reward.

• What a CEO change at Yeo Hiap Seng means for a quiet consumer staple in your income plan.

• Why IPO stabilising trades in Foundation Healthcare are mechanics, not secret bullish signals.

• How CICT’s Paragon plans fit into the wider story of REIT capex and your future DPU.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Friday’s STI pullback looked like “red across the board”, but the real story was much narrower, UOB taking a bigger hit than DBS and OCBC after a Citi analyst questioned whether its asset quality turnaround has been quietly over‑priced into expectations. At the same time, Hin Leong’s US$2.6 billion claim against Deloitte was struck out by Singapore’s Court of Appeal, a reminder that clean audits do not shield you from management’s trading decisions. In this episode, Angela and I walk through how those two headlines connect for a CPF and SRS investor who thinks of banks as safe and audits as comfort. The goal is not to scare you, it is to show you where the real boundary lines are so you stop outsourcing risk management to labels that do less work than you think.

Key takeaways:

• UOB fell about 2.4%, while DBS and OCBC slipped less than 1%, showing name specific risk.

• A Citi analyst warned UOB’s upcoming earnings could miss once one off income is stripped out.

• The latest 6 month T‑bill auction cleared at 1.50%, up from 1.47%, contradicting the “rates must fall soon” story.

• Hin Leong’s US$2.6 billion trading loss claim against Deloitte was struck out, leaving only US$90 million dividends and S$612,000 fees on the table.

• The Court of Appeal explicitly ruled those trading losses “too remote”, limiting how far audit liability stretches for investors.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

The market opened about 0.7% higher on Wednesday, still riding last night’s GDP optimism, but today’s tape is pure stock picker territory. I walk through why SIA’s 3.7 million June passengers and 6.3% growth are great operationally yet do not settle the income-quality question around specials versus core cashflow, especially if you are leaning on that dividend for CPF or SRS. We then unpack a S$2.13 billion Bayshore bid that will reshape an entire east coast rental story, Lum Chang’s double‑header of a new Teck Ghee Station contract and a mainboard move, and CLAR’s 32%‑premium data centre divestment that screams strong capital recycling without getting a shortcut zone verdict. Along the way I clean up the Foundation Healthcare versus Fullerton Healthcare naming confusion and admit openly where the AEM work is still on my own to‑do list instead of pretending there is a view.

Key takeaways:

• SIA and Scoot carried 3.7 million passengers in June, up 6.3% year on year, but dividend reliability still hinges on the mix of specials versus core business.

• A Frasers Property‑led consortium topped the Bayshore bid at about S$2.13 billion, S$1,323 psf ppr, setting up up to 1,280 new homes over Bedok South MRT and a fresh retail story.

• Lum Chang secured a S$32.9 million Teck Ghee Station contract and saw Lum Chang Creations move from Catalist to the mainboard on the same day, a rare double headline for this name.

• CapitaLand Ascendas REIT is divesting Kim Chuan Telecommunications Complex for about S$200.4 million, double the S$100 million 2005 purchase price and roughly 32% above last month’s valuation, a textbook capital recycling result without a formal zone call.

• Foundation Healthcare’s stabilising manager bought another 850,000 shares after an earlier 4.5 million purchase, and we confirm clearly it is a different company from Fullerton Healthcare, closing that loop for listeners.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

DBS just became the first Singapore stock to cross S$200 billion, yet the income case for a fresh buyer at today’s prices is more fragile than the headline suggests. In this episode I walk Angela through why Citi can lift targets on all three local banks and still keep UOB at neutral, and why that cautious stance quietly lines up with my own wait and see on the sector. We then zoom out to the week’s pullback in STI names, from SIA and Keppel to YZJ, and connect it to Singapore’s latest GDP print where Middle East tensions finally show up in hard numbers instead of just market chatter. If you are building retirement cashflow from CPF and SRS, this is a walkthrough of why record bank valuations and solid balance sheets do not automatically clear your 4.7% yield hurdle today.

Key takeaways:

• DBS crosses S$200 billion market cap, first Singapore listed company to do it.

• Citi lifts target prices on DBS, OCBC and UOB, but keeps UOB at neutral.

• STI slips about 0.6 per cent as cyclicals like YZJ, Keppel and SIA see 1 to 2 per cent red days.

• Singapore’s GDP growth cools from around mid 6 per cent to the mid 5 per cent range as Middle East tensions weigh on exports.

• COE premiums for commercial vehicles hit a fresh record, adding cost pressure for small businesses on top of regular car COEs.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

This week’s Daily Pulse walks through one of the strongest bank rallies Singapore has seen in a while, with DBS, OCBC and UOB all punching out fresh highs and dragging the Straits Times Index up with them. Angela brings the human angle, her husband cheering a big DBS week, while I stay pinned to the numbers that matter for someone using CPF and SRS for income.

We separate the growth story the analysts are upgrading, from the income story your portfolio actually lives on, and show how every leg higher in price quietly makes fresh entries harder for a yield-focused investor.

We also flag smaller movers, from UOB Kay Hian and PanUnited on the upside to First Resources and the tech names on the downside, plus two MAS proposals that could widen the future toolkit for retail portfolios without changing this week’s stock picture.

Key takeaways:

• DBS, OCBC and UOB all hit new highs, powering a 4.29% STI jump for the week.

• At S$70.45 DBS and S$27.43 OCBC, new buyers lock in thinner income than a month ago.

• Macquarie and Citi upgrades lift price targets into the S$70–S$45 range, but speak to growth, not immediate cashflow.

• UOB’s double digit weekly move still sits in a “wait for earnings” bucket, with no forensic verdict before the 7 August numbers land.

• MAS’ consultation on alternative funds and new corporate structures could eventually add futures-based commodity funds and single country bond funds to retail menus.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Key takeaways:

• Indonesia’s 3.4 GW power export plan reshapes Singapore’s future energy mix, not July’s bill

• Sembcorp’s role in cross‑border projects leans growth‑story first, yield‑story later

• A 17 per cent tariff jump maps to roughly S$17–20 more for a four‑room HDB household

• DFI’s CFO‑to‑CEO shuffle signals continuity, not crisis, in its Food division

• Daily Pulse episodes are for staying ahead of policy shifts before they hit your DPU

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Key takeaways:

• Why a seized S$42m Nvidia mansion and legal AI demand both touch your dividend plan.

• What a record-high STI actually means for bank-heavy CPF and SRS portfolios.

• Why CMS, AvePoint and First Resources can be hot movers yet still fail income tests.

• How DBS, OCBC and SIA’s zone verdicts help you separate momentum from true safety.

• Why weekly gainers and losers are data points, not instructions, for your retirement plan.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Key takeaways:

• Why a 51.3 PMI helps your export‑linked stocks but not your zi char landlord.

• How a 17% electricity and 7.1% gas hike shows up in REIT rental reversions.

• Why domestic F&B and retail tenants face margin stress while AI‑exposed manufacturers enjoy tailwinds.

• What Frasers’ CEO transition and SGX’s custody model shift mean for a long‑term CPF/SRS investor.

• Why “strong Singapore economy” headlines can hide a dangerous two‑speed reality for retirement income.

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Key takeaways:

• Electricity tariffs are rising 17%, to 31.91 cents per kWh before GST, adding about S$17 a month for a four room flat

• Headline inflation at 1.8% and core at 1.4% can still hide sharp pain in energy and utilities for HDB households

• A “growth” story like SIA’s Air China joint venture improves routes and traffic but does not change existing dividend flags

• The real stress test for your CPF and SRS portfolio is whether your income is rising faster than your electricity and gas bills, not just whether prices look calm on paper

• Rising utility costs can squeeze REIT and corporate margins the same way they squeeze your household budget, which is why forensic metrics like gearing and interest coverage matter before any DPU cut lands

Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.